Some research suggests the stomach bleed risk comes from the platelet inhibition itself, which would mean you can't have the good effect without the bad.
Daily dose suppressed PGE2 while 3-daily dose didn't.
> Since PGE2 is involved in gastric healing, we understand that this new approach could be safer and as efficient as the standard daily therapy on a long-term basis.
